---
schema_version: "secwatch.filing_event.v1"
accession: "0000898432-22-000615"
form_type: "8-K"
ticker: "IRMD"
cik: "0001325618"
company_name: "IRADIMED CORP"
filed_at: "2022-10-06T23:59:59+00:00"
generated_at: "2026-06-23T04:57:14.027760+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# iRadimed appoints Hilda Scharen-Guivel to Board of Directors, effective Oct 4, 2022

## Summary
- Board expanded to five directors; three are independent, including Scharen-Guivel.
- Scharen-Guivel recently retired from FDA as Program Director of CDRH; 25+ years in federal agencies.
- She will receive standard non-employee director compensation per 2022 proxy statement.
- Scharen-Guivel has no material relationship with iRadimed; no transactions under Item 404(a).

## SEC filing metadata
- accession: 0000898432-22-000615
- form_type: 8-K
- ticker: IRMD
- cik: 0001325618
- company_name: IRADIMED CORP
- filed_at: 2022-10-06T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1325618/000089843222000615/0000898432-22-000615-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1325618/000089843222000615/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000898432-22-000615
- JSON: https://secwatch.observer/filing/0000898432-22-000615.json
- Plain text: https://secwatch.observer/filing/0000898432-22-000615.txt

## Key facts
- Executive change
  Hilda Scharen-Guivel was elected as Director at IRADIMED CORP.
  - Action: elected
  - Role: Director
  source text: elected Ms. Hilda Scharen-Guivel as a Director, both effective October 4, 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1325618/000089843222000615/0000898432-22-000615-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.